Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Starts Second Half Strongly; Millipore Added

The BCW Index has started the second half of 2006 strongly with a gain of 3.4 percent for the shortened trading week ended Monday. The Nasdaq Biotech Index outpaced the BCW Index, climbing 5.2 percent, while the Nasdaq gained 4.3 percent, and the Dow Jones Industrial Average rose 2.8 percent. Every stock in the Index gained ground for the tracking period, with Stratagene leading the way with a rise of 12.7 percent. Qiagen and Fisher Scientific both rose more than 6 percent for the week.

Starting this week, Millipore has been added to the Index and will receive regular coverage in BioCommerce Week. The firm is in the process of acquiring Serologicals. After listing its capital equipment business as discontinued operations, Harvard Bioscience has been dropped from the Index.

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(July 3, 2006)
Last Price
(June 27, 2006)
% change
Agilent
A
31.86
30.44
4.7
Applied Biosystems
ABI
32.84
32.15
2.1
Beckman
BEC
55.89
53.43
4.6
Bio-Rad
BIO
65.55
64.35
1.9
Bruker
BRKR
5.29
5.24
1.0
Fisher Scientific
FSH
73.68
69.27
6.4
GE
GE
33.33
32.88
1.4
Invitrogen
IVGN
66.10
64.89
1.9
Millipore
MIL
62.25
61.30
1.5
Molecular Devices
MDCC
30.21
29.45
2.6
PerkinElmer
PKI
21.27
20.35
4.5
Qiagen
QGEN
13.74
12.89
6.6
Sigma
SIAL
72.59
70.70
2.7
Stratagene
STGN
6.39
5.67
12.7
Thermo
TMO
36.42
34.03
7.0
Waters
WAT
44.48
43.19
3.0
BCW Index Average
40.74
39.39
3.4
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.